Background: One of the most common differential diagnosis for a white patch in throat is diphtheria. Diphtheria is an acute infectious disease caused by toxigenic strains of corynebacterium diphtheriae. These bacilli release powerful exotoxin which is responsible for formation of white or greyish or yellowish membrane commonly over tonsils, pharynx or larynx. The objectives of the study were to determine the clinical and epidemiological factors of cases admitted with white patch in throat; to assess the microbiological confirmation rate of diphtheria among cases with white patch in throat; to identify the mortality and morbidity among study population. Methods: A cross sectional record based retrospective study was carried out at Sir Ronald Ross Institute of Tropical & Communicable Diseases, Hyderabad. All the cases admitted in year 2016 with a white/grey/yellowish patch in throat were included in the study. The study was carried out for 2 months. Results: A total of 230 cases were reported and 46.1% of cases were in the age group of 11-20 years. Males constituted about 48.3% and females 51.7% of study population. The most common clinical presentation was Sore throat, fever and a pseudo membrane over tonsils/pharynx. A total of 12 deaths occurred among 230 cases. Conclusions: Deaths occurred most commonly in the younger age group and in the non-immunized. Recovery was faster and the course of illness was uncomplicated in the older age group and in completely immunized individuals.
INTRODUCTION
Diphtheria is a rare disease in most developed countries owing to routine children vaccination. Diphtheria is an endemic disease in India. A total of 4090 cases were reported in India in the year 2013, and about 64 deaths were reported. 1 One of the most common differential diagnosis of white or grey patch in throat is diphtheria. Diphtheria is an acute infectious disease caused by the bacterium corynebacterium diphtheriae, and primarily infects the throat and upper airways. The organism produces an exotoxin which affects myocardium and kidneys. The common clinical presentation is sore throat, low fever and swollen glands in the neck, usually giving an appearance of "bull neck". In severe cases, the toxin attaches to myocardium causing myocarditis or peripheral neuropathy. The diphtheria toxin causes a membrane of dead tissue to build up over the throat and tonsils, which is white or grey or yellowish in color. The adherent membrane in throat makes breathing and swallowing difficult. The disease is spread through direct physical contact or from breathing in the aerosolized secretions from coughs or sneezes of infected individuals. 2 Vaccination against diphtheria has reduced the mortality and morbidity drastically; however diphtheria is still a significant child health problem in countries with poor immunization coverage. In countries endemic for diphtheria, the disease occurs mostly as sporadic cases or in small outbreaks. Diphtheria is fatal in 5 -10% of cases, with a higher mortality rate in young children. Treatment involves administering diphtheria antitoxin to neutralize the effects of the toxin, as well as antibiotics to kill the bacteria. 2 This study was conducted to assess the clinical and epidemiological profile of clinical diphtheria such as the frequency in children and adults, seasonal variation, gender predisposition, relationship between clinical disease and immunization status, rate of complications, case fatality rate. 
Objectives of study

Case definition as per WHO guidelines 3
Clinical description
An illness characterized by laryngitis or pharyngitis or tonsillitis, and an adherent membrane of the tonsil, pharynx and/or nose.
Laboratory criteria for diagnosis
Isolation of Corynebacterium diphtheriae from a clinical specimen, or a fourfold greater rise in serum antibody (but only if both serum samples are obtained before the administration of diphtheria toxoid or antitoxin)
Case classification 3
Probable: A case that meets the clinical description
Confirmed: A case that is laboratory confirmed or linked epidemiologically to a laboratory confirmed case.
The immunization status was documented as per the information given by the parents. Those who had received three primary doses at 4-6-week intervals starting at 1 month of age, followed by booster doses at 18 months and 5 years were recorded as "Immunized". Those who had not received any dose were considered "Unimmunized". Patients who had missed one or more of the three primary doses or booster doses were included as "Partially immunized".
The study duration was for a period of 2 months. A pre tested and pre designed proforma was used to obtain information from medical records. The data was analyzed retrospectively with respect to demographic details, clinical features, laboratory confirmation reports, immunization status, complications and mortality using MS excel and open epi.
Treatment protocol
All patients with a clinical suspicion of diphtheria were given parenteral crystalline penicillin, L-Carnitine. Antidiphtheritic serum (ADS) will be given in a single dose as recommended depending on the site and extent of disease. Throat swab for Albert's stain and culture will be sent in all, at the time of admission. Those patients who developed complications like airway obstruction, myocarditis were given treatment in the form of Tracheostomy and ventilator support.
RESULTS
A total of 230 cases were admitted with white patch in throat from January 2016 to December 2016 at Sir Ronald Ross Institute of Tropical and Communicable diseases (SRRITCD)/Govt. Fever Hospital, (tertiary care center) Hyderabad, India. In the present study the Mean age of study population was 12.56±6.9 years. Maximum incidence of disease (46.1%) was found in the age group of 11-20 years and around 43.4% was found in the age group of 0-10 years. Least disease burden was found in the age group of 41-50 years. In the present study, the disease was found to be higher among females (51.7%) as compared to males (48.3%).
Highest disease burden was found among Muslims (52.2%), followed by Hindus (43.9%). Around 3.9% of cases were Christians. In the present study, around 64.3% of cases were registered in the months of August, September and October (corresponding to rainy season). It was found that highest number of cases (23.9%) were recorded in the month of September, followed by August (22.6%) and 17.8% in October. Around 16.5% of cases were recorded in the months of November and December (corresponding to winter season). Least number of cases (0.9% each) were recorded in the months of April, May and June.
In the present study it was found that mean duration between onset of symptoms and first contact with health centre was 4-5 days. In the present study it was found that the most common presentation in all study subjects was fever with sore throat/throat pain and white membrane in the throat.
Around 42.2% of study subjects also had complaints of running nose. Bull neck was found in 24.3% of diphtheritic cases. Around 4.3% of study subjects had stridor at the time of presentation. 
Number of cases
Immunization status
Unimmunized
Partially Immunized
Completely Immunized Unknown 16 cases constituting 6.9% of study population and culture was positive in 113 cases constituting 49.1% of total study population. Thus, the microbiological confirmation rate was 56.1% among the study population.
In this study it was found that 30.9% of study population were unimmunized and 20.4% of study population were partially immunized and 10% of study population were completely immunized. Around 38.7% of cases did not have a mention about their immunization status in their case records. Around 82.6% of study population, did not develop any complications. There were no complications among the immunized individuals. Around 6.9% of study population developed respiratory stridor and 6.5% of study population developed myocarditis. Almost 5.2% of study population developed myocarditis and respiratory stridor.
In all the 16 patients (6.9%) who developed respiratory stridor, tracheostomy was done to relieve airway obstruction. Among 15 patients who developed Myocarditis (6.5%) was treated with L carnitine and antidiphtheritic serum. The recovery rate was very less once the patient had developed complications. Among a total of 16 patients who developed complications, 12 patients succumbed to death. Using Fisher exact test of significancep statistically highly significant <0.0001.
The cure rate in the present study was found to be 92.2% and the case fatality rate was 5.2%. Mean age of study population who had fatality was found to be 10 years. Mean duration in days between admission and discharge was found to be 7 days.
In the present study it was found that cure rate among study subjects without any complications was 100% and 25% among those who had complications like myocarditis or/and respiratory stridor. The difference was found to be statistically highly significant using Fisher exact test.
DISCUSSION
In the present study the maximum incidence of disease (46.1%) was found in the age group of 11-20 years. This findings were concurrent with a study conducted by Basavaraja et al where 74.1% of cases were found in >5 years of age group. 4 The present study findings were different when compared to a study conducted by Singh et al, where maximum incidence (92.5%) of disease was found in 0-10 years of age group. 5 In the present study only 43.4% was found in the age group of 0-10 years.
The study findings also differed with a study conducted in Gujarat where maximum disease burden was found among <5 years of age. 6 The shifting trend in disease occurrence can be attributed to immunization coverage.
In the present study the Mean age of study population was 12.56±6.9 years. This finding was similar to a study by Sailaja et al where median age of study subjects was 17 years. 7 In the present study, the disease showed a female preponderance (51.7%) was slightly higher compared to males (48.3%). These findings were similar to a study by Maheriya et al 8 where disease burden was 63% among females and 37% among males.
The study findings in relation to religion and region distribution were similar to a study conducted by Vijay Kumar et al where Muslims (60%) and urban area residents (83%) dominated the study subjects. 9 In this study maximum incidence of disease burden (64.3%) was found in rainy season (August -October) followed by winter months (November-December) -16.5%. Similar findings were found in a study by Kumar et al. 9 The major clinical features in the present study were mild to moderate fever, sore throat, and a pseudomembrane on examination (100%). Additional presenting features included malaise, throat pain, cough, rhinitis, dyspnea, orthopnea and dysphagia. Around 42.2% of study subjects also had complaints of running nose. Bull neck was found in 24.3% of diphtheritic cases. Around 4.3% of study subjects had stridor at the time of presentation. In the present study, it was found that 10% of immunized individuals developed the disease and around 30.9% of unimmunized individuals developed the disease. These findings concurred with a study by Bandichhode et al where 11.11% of immunized individuals and 58.3% of unimmunized individuals developed the disease. 11 The common complications in the present study were myocarditis and respiratory stridor. A total of 16 patients developed airway obstruction and tracheostomy was done among them to relieve the obstruction. This findings were similar to a study by Singh et al and Maheriya et al where the common complications were myocarditis and stridor due to palatal paralysis. 5, 8 The cure rate in the present study was found to be 92.2% and the case fatality rate was 5.2%. The case fatality rate was higher (23.67%) when compared to a present study in a study conducted by Maheriya et al and the case fatality rate was only 1.8% in a study by Kumar et al. 8, 9 
CONCLUSION
The higher prevalence of diphtheria in age group of 11-20 years suggests the need for completing immunization with booster doses.
There was significantly higher mortality among cases who developed complications like myocarditis and respiratory stridor.
Early diagnosis and standard treatment protocol consisting of anti-diphtheritic serum (ADS), antibiotics like penicillin and L carnitine to prevent myocarditis has helped in achieving a cure rate of 92.2% in the present study.
Since, the vaccine is a toxoid and is not directed towards the organism, immunization does not prevent carrier state and hence immunization rate must be maintained at a very high level to curb outbreaks of diphtheria in community.
Limitations
As it's a hospital based retrospective study, data related to immunization was missing in few case sheets. Subjects who left against medical advice could not be retrieved with regards to their outcomes and all the findings of this study cannot be generalized to community.
